# Minocycline for Aneurysmal Subarachnoid Hemorrhage (MASH)

> **NCT04876638** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Southern California** · enrollment: 20 (estimated)

## Conditions studied

- Aneurysm, Ruptured
- Vasospasm, Intracranial
- Delayed Cerebral Ischemia
- Blood Brain Barrier Defect

## Interventions

- **DRUG:** Minocyclin

## Key facts

- **NCT ID:** NCT04876638
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-07-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04876638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04876638, "Minocycline for Aneurysmal Subarachnoid Hemorrhage (MASH)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04876638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*